Pharmanutra S.p.A.

Milan Stock Exchange:PHN.MI

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🏬 Consumer Packaged Goods

💊 Drugstores & Retail Pharmacies

🛍 Retail & Wholesale

🛍 Specialty Retail

Location

Italy

Market Cap

USD 510.15 M

Share Price

USD 53.19

Avg Daily Volume

9,931

Change (1 day)

0.26%

Change (1 year)

7.00%

Change (YTD)

-6.04%

Pharmanutra S.p.A. Share Price on June 23, 2025: USD 53.19

Pharmanutra S.p.A. Share Price is USD 53.19 on June 23, 2025, a 7.00% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

Pharmanutra S.p.A. 52-week low Share Price is USD 66.65 on June 23, 2025, which is 25.31% above the current Share Price.
Pharmanutra S.p.A. 52-week low Share Price is USD 49.78 on June 23, 2025, which is -6.42% below the current Share Price.
Pharmanutra S.p.A. average Share Price for the last 52 weeks is USD 56.89.

Daily

From:

To:

Zoom:

Key data

Date	Share Price	Share Price	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)

Milan Stock Exchange: PHN.MI

Pharmanutra S.p.A.

CEO	Mr. Andrea Lacorte
IPO Date	July 18, 2017
Location	Italy
Headquarters	Via delle Lenze 216/B
Employees	118
Sector	🏥 Health Care
Industries Pharmaceuticals 🏬 Consumer Packaged Goods 💊 Drugstores & Retail Pharmacies 🛍 Retail & Wholesale 🛍 Specialty Retail

Description

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.